Gut-licensed IFNγ+ NK cells drive LAMP1+TRAIL+ anti-inflammatory astrocytes

Liliana M. Sanmarco,Michael A. Wheeler,Cristina Gutiérrez-Vázquez,Carolina Manganeli Polonio,Mathias Linnerbauer,Felipe A. Pinho-Ribeiro,Zhaorong Li,Federico Giovannoni,Katelyn V. Batterman,Giulia Scalisi,Stephanie E. J. Zandee,Evelyn S. Heck,Moneera Alsuwailm,Douglas L. Rosene,Burkhard Becher,Isaac M. Chiu,Alexandre Prat,Francisco J. Quintana
DOI: https://doi.org/10.1038/s41586-020-03116-4
IF: 64.8
2021-01-06
Nature
Abstract:Astrocytes are glial cells that are abundant in the central nervous system (CNS) and that have important homeostatic and disease-promoting functions<sup><a href="/articles/s41586-020-03116-4#ref-CR1">1</a></sup>. However, little is known about the homeostatic anti-inflammatory activities of astrocytes and their regulation. Here, using high-throughput flow cytometry screening, single-cell RNA sequencing and CRISPR–Cas9-based cell-specific in vivo genetic perturbations in mice, we identify a subset of astrocytes that expresses the lysosomal protein LAMP1<sup><a href="/articles/s41586-020-03116-4#ref-CR2">2</a></sup> and the death receptor ligand TRAIL<sup><a href="/articles/s41586-020-03116-4#ref-CR3">3</a></sup>. LAMP1<sup>+</sup>TRAIL<sup>+</sup> astrocytes limit inflammation in the CNS by inducing T cell apoptosis through TRAIL–DR5 signalling. In homeostatic conditions, the expression of TRAIL in astrocytes is driven by interferon-γ (IFNγ) produced by meningeal natural killer (NK) cells, in which IFNγ expression is modulated by the gut microbiome. TRAIL expression in astrocytes is repressed by molecules produced by T cells and microglia in the context of inflammation. Altogether, we show that LAMP1<sup>+</sup>TRAIL<sup>+</sup> astrocytes limit CNS inflammation by inducing T cell apoptosis, and that this astrocyte subset is maintained by meningeal IFNγ<sup>+</sup> NK cells that are licensed by the microbiome.
multidisciplinary sciences
What problem does this paper attempt to address?